Tim Heffernan
@timheff5
Followers
364
Following
737
Media
19
Statuses
175
Joined November 2016
@LabGenovese “EMT favours the emergence of genomic-unstable, highly fit tumour cells, which strongly supports the concept of cell-state-restricted patterns of evolution” @MDAndersonNews
nature.com
Nature - Malignant cells with mesenchymal features display increased chromatin accessibility, particularly in the pericentromeric and centromeric regions, in turn resulting in delayed mitosis and...
1
5
31
RT @MDAndersonNews: It was a busy day at the MD Anderson booth today at #SITC24. Check out who will be in the booth tomorrow at https://t.c….
0
3
0
RT @OnlyInBOS: The Boston Celtics are NBA Champions!. The NBA team with the most championship trophies!
0
2K
0
RT @MDAndersonNews: Thank you to everyone who stopped by our booth at #AACR24 to discuss the latest cancer research advances. We hope to se….
0
10
0
RT @Aiims1742: Another KRAS inhibitor enters the clinic. This is @Boehringer orally bioavailable multiKRASi BI-3706674 currently undergoing….
0
16
0
RT @Aiims1742: Team @MDAndersonNews has landed at Kiawah for the @break_cancer summit. Ready for three days of #RadicalCollaboration! .#BTC….
0
13
0
RT @RareCancerRF: We empower patients with #rarecancers to donate their tissue to research happening at leading institutions + labs through….
0
4
0
RT @Aiims1742: Huge congratulations this morning to @rkalluriMDPhD & especially two @KalluriLab MVPs - Kate McAndrews @krishnaniyer199 - fo….
0
7
0
RT @MDAndersonNews: Want to accelerate your research with industry collaboration?. Learn how from our Jean Gilbert, Dr. Tim Heffernan and D….
0
2
0
RT @generate_biomed: In an interview w/ @endpts, our CEO @mike_nally & @timheff5 provide their perspectives on Generate’s newest collaborat….
0
2
0
The agenda will feature @CKadoch, @GhayasIssa, @CMullighan, @roelverhaak, @LabGenovese, @notSoJunkDNA, @corrie_painter, @MarkLaabs, @MoonyTseng, @VivekSubbiah, and others. Join us in Houston on May 4th. @gdraetta.
0
0
9
RT @MDAndersonNews: “The ability to build an expansive catalog of disease models opens new avenues to advance impactful medicines,” says ou….
mdanderson.org
MD Anderson and Xilis announced a strategic collaboration to deploy Xilis' proprietary MicroOrganoSphere technology in support of preclinical research to accelerate the development of novel cancer...
0
4
0
RT @rkalluriMDPhD: Stellar team work between different groups at @MDAndersonNews and the @break_cancer killing ras group there @timheff5 @A….
0
13
0
RT @MDAndersonNews: MD Anderson is collaborating with @Xilis_Inc to support preclinical research to accelerate the development of novel can….
0
4
0
Thinking about my buddy Ken Scott. It’s been 5 years since we said goodbye to the original honey badger. His legacy lives on as we innovate new approaches to #endcancer. Cheers my friend!
0
1
17
RT @GreenLymphoLab: We have an open computational biology postdoc position. We're a lab with strong funding, mentorship + career developmen….
0
21
0
RT @JimRayNDC: Check out our new website! Alzheimer’s disease drug discovery, new targets, you know all the good things in life. Like and….
belferndc.org
The Belfer Neurodegeneration Consortium (BNDC) mission is to discover breakthrough therapies that slow, stop, or reverse neurological disorders such as Alzheimer’s disease and Parkinson’s disease.
0
9
0
RT @MDAndersonNews: “Our research raises the possibility that the AR and testosterone may be at play and offers a new target to improve res….
mdanderson.org
Androgen receptor (AR) signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers from The University of Texas MD Anderson Cancer Center showed in a...
0
5
0